Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 11:15:1352300.
doi: 10.3389/fpsyt.2024.1352300. eCollection 2024.

Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population

Affiliations

Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population

Cecilia L Bergeria et al. Front Psychiatry. .

Abstract

Objective: There are substantial barriers to conducting research among individuals with stigmatized and complicated health conditions like substance use disorders. These barriers slow progress when developing, refining, and assessing interventions to better treat underserved populations. Virtual focus groups are an innovative method for collecting data from individuals via a discreet and accessible platform which can inform novel as well as existing treatment approaches. This article reports on the feasibility and acceptability of virtual focus groups as a mechanism to recruit and engage geographically and demographically diverse samples of participants with substance use disorders that are otherwise logistically difficult to assess.

Method: Participants were assessed for eligibility for a virtual focus group study based on demographic features, drug use history, and psychiatric history via a remote, interview-based screening. Focus groups were completed anonymously without video or name-sharing. Discussion contributions, quantified with number of times speaking and total number of words spoken, were compared across gender, and treatment status. Participants provided quantitative and qualitative feedback on the focus group experience in a follow-up survey.

Results: Focus groups (N=26) based in geographical areas throughout the United States were conducted with 88 individuals with opioid use disorder or stimulant use disorder. Discussion contributions were comparable between genders and among individuals in treatment versus those seeking treatment. A follow-up survey (n=50, 57% of focus group participants) reflected high levels of enjoyment, comfort, and honesty during focus group discussions.

Discussion: Findings suggest virtual focus groups can be an effective and efficient tool for substance use research.

Keywords: focus groups; opioid use disorder; remote data collection; stimulant use disorder; virtual.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Diagram for participant flow during the virtual focus group set-up.
Figure 2
Figure 2
Map with pinpoints of zip codes corresponding to participants who participated in area specific focus groups (organized by color).

References

    1. Bergeria CL, Strain EC. Opioid use disorder: pernicious and persistent. Am J Psychiatry. (2022) 179:708–14. doi: 10.1176/appi.ajp.20220699 - DOI - PubMed
    1. Clement S, Schauman O, Graham T, Maggioni F, Evans-Lacko S, Bezborodovs N, et al. . What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med. (2015) 45:11–27. doi: 10.1017/s0033291714000129 - DOI - PubMed
    1. Hoffman KA, Baker R, Kunkel LE, Waddell EN, Lum PJ, McCarty D, et al. . Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial. BMC Health Serv Res. (2019) 19:862. doi: 10.1186/s12913-019-4721-x - DOI - PMC - PubMed
    1. Nalven T, Spillane NS, Schick MR, Weyandt LL. Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review. Exp Clin Psychopharmacol. (2021) 29:524–38. doi: 10.1037/pha0000510 - DOI - PMC - PubMed
    1. Gunn CM, Pankowska M, Harris M, Helsing E, Battaglia TA, Bagley SM. The representation of females in clinical trials for substance use disorder conducted in the United States, (2010–19). Addiction. (2022). doi: 10.1111/add.15842 - DOI - PMC - PubMed

LinkOut - more resources